Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,514,400
- Avg volume
- 336,464
- Day's range
- $0.00 – $0.01
- Shares out
- —
- Stochastic %K
- 13%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products a...
Show more
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products at affordable prices. The company was incorporated in 1986 and is based in Yichun, China.
- Industry
- Engineering & Construction
- Sector
- Industrials
- Address
- Jingshuo Building, 7th Floor Big Data Industrial Park, Yichun, China
Latest news
No headlines yet.
